BioCentury
ARTICLE | Clinical News

Quilvax-M: Began Trials

July 26, 1999 7:00 AM UTC

Aquila Biopharmaceuticals Inc. (AQLA), Framingham, Mass. Product: Quilvax-M Business: Agbio/Veterinary/Environmental Therapeutic category: Immune stimulation Target: Staphylococcus aureus Indication: ...